Table 1.
Description | N | Gender (%Female) | Mean Age (min-max) | |
---|---|---|---|---|
T-stage | M1 disease at dx | 5 | 40 | 66 (44–85) |
T1 < =1.00 mm | 60 | 42 | 55 (28–84) | |
T2 = 1.01–2.00 mm | 32 | 66 | 62 (31–88) | |
T3 = 2.01–4.00 mm | 29 | 41 | 63 (24–88) | |
T4> 4.00 mm | 17 | 29 | 63 (37–81) | |
Unclassified | 6 | |||
Recurrence | Yes | 86 | 50 | 57 (28–84) |
No | 63 | 40 | 62 (24–88) | |
T-stage/Recurrence | T1-T2/No recurrence | 74 | 51 | 56 (28–84) |
T3-T4/Recurrence | 34 | 34 | 63 (24–88) | |
DFS 5 y | Yes | 91 | 49 | 58 (24–88) |
No | 58 | 40 | 61 (30–88) | |
Metastasis status at follow-up | M1 at diagnosis | 5 | 40 | 66 (44–85) |
Metastasis | 43 | 44 | 56 (24–82) | |
No metastasis | 101 | 47 | 60 (28–88) | |
Location of the tumor | Face | 17 | 53 | 65 (31–88) |
Lower part of body | 41 | 73 | 57 (30–85) | |
Trunk | 5 | 20 | 56 (29–84) | |
Upper part of body | 82 | 32 | 60 (24–88) | |
Unclassified | 4 | |||
Ulceration | Yes | 27 | 41 | 61 (30–84) |
No | 37 | 43 | 58 (28–88) | |
Unclassified | 85 |
Sample demographics of the melanoma patients. DSF; Disease-free survival (5 years).